Excelimmune's mission is to become the leader in Antibody Combination Therapeutics (ACT), creating life-saving medicines to combat debilitating diseases.
We are actively seeking collaborations from interested parties.
The company's vision is to leverage the diversity, specificity and power of the human body's natural immune system, combining the most potent antibodies from many individuals into highly effective therapeutics. Excelimmune believes that its technology has the potential to fundamentally change the way we approach the treatment of antibiotic resistant infections, cancer and other diseases by reducing the selective pressure that leads to the failure of antibiotics, monoclonal antibodies and other single-mechanism drugs.
Excelimmune welcomes you and invites you to find out more about us and our technology.